Bismuth Subcitrate Potassium, Metronidazole, And Tetracycline Hydrochloride
Product Images NDC 61269-385

3 FDA label images from H2-pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole, And Tetracycline Hydrochloride (NDC 61269-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bismuth 01)

Chemical Structure (Bismuth 01)
Chemical structure of metronidazole, one of the active ingredients in Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride. The diagram shows the molecular arrangement with functional groups including a nitro group (NO2) attached to a heterocyclic ring.*
FDA Label Image

Chemical Structure (Bismuth 02)

Chemical Structure (Bismuth 02)
Chemical structure diagram depicting the molecular structure of the active ingredient Tetracycline Hydrochloride. The image shows detailed bonds and functional groups characteristic of tetracycline with an associated hydrochloride (HCl) notation.*
FDA Label Image

Principal Display Panel (120 Capsule Blister Card Box)

Principal Display Panel (120 Capsule Blister Card Box)
Packaging label for Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride Capsules, 140 mg/125 mg/125 mg, a 10 Day Therapy PAK distributed by H2-Pharma, LLC. The package contains 120 capsules in 10 blister cards, each card having 4 blisters with 3 capsules per blister. The label indicates this is a combination therapy for the eradication of Helicobacter pylori infection. The product is made in Canada and includes branding for Juvise Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.